HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rina Dalva Neubarth Giorgi Selected Research

Hematologic Neoplasms (Hematological Malignancy)

5/2015[Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rina Dalva Neubarth Giorgi Research Topics

Disease

9Rheumatoid Arthritis
11/2021 - 05/2011
2Infections
03/2024 - 07/2015
2Neoplasms (Cancer)
05/2015 - 08/2012
1Dyslipidemias (Dyslipidemia)
01/2021
1Pain (Aches)
01/2020
1Latent Tuberculosis
07/2015
1Bacterial Infections (Bacterial Infection)
05/2015
1Rheumatic Diseases (Rheumatism)
05/2015
1Tuberculosis (Tuberculoses)
05/2015
1Hematologic Neoplasms (Hematological Malignancy)
05/2015
1Hereditary Complement Deficiency Diseases
02/2013
1Chickenpox
02/2013
1Hepatitis A (Hepatitis, Infectious)
02/2013
1Human Influenza (Influenza)
02/2013
1Tetanus
02/2013
1Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2012
1Atherosclerosis
08/2012
1Osteoporosis
08/2012
1Hypertension (High Blood Pressure)
08/2012
1Diabetes Mellitus
08/2012
1Venous Thrombosis (Deep-Vein Thrombosis)
08/2012
1Arthritis (Polyarthritis)
05/2011

Drug/Important Bio-Agent (IBA)

3ametantrone (HAQ)IBA
03/2024 - 05/2011
3Adrenal Cortex Hormones (Corticosteroids)IBA
03/2024 - 08/2012
3Antirheumatic Agents (DMARD)IBA
06/2021 - 02/2013
2VaccinesIBA
05/2015 - 02/2013
1Anti-Bacterial Agents (Antibiotics)IBA
03/2024
1Janus Kinase InhibitorsIBA
11/2021
1GlucocorticoidsIBA
01/2021
1N-phthaloylglutamic acidIBA
01/2020
1tofacitinibIBA
11/2015
1Tuberculin (PPD)IBA
07/2015
1Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
02/2013
1Rituximab (Mabthera)FDA Link
02/2013
1AntibodiesIBA
02/2013
1BCG VaccineFDA Link
02/2013
1Hepatitis B Surface Antigens (HBsAg)FDA Link
02/2013
1Immunoglobulins (Immunoglobulin)IBA
02/2013
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
02/2013
1Meningococcal Vaccines (Meningococcal Vaccine)IBA
02/2013
1Papillomavirus Vaccines (HPV Vaccines)IBA
02/2013
1LDL CholesterolIBA
08/2012
1Vitamin DFDA LinkGeneric
08/2012
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
08/2012
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2012
1Dietary CalciumIBA
08/2012
1Angiotensin Receptor AntagonistsIBA
08/2012
1CalciumIBA
08/2012
1Anti-Citrullinated Protein AntibodiesIBA
05/2011
1Acute-Phase Proteins (Acute-Phase Protein)IBA
05/2011
1Rheumatoid FactorIBA
05/2011
11- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA
05/2011
1cyclic citrullinated peptideIBA
05/2011

Therapy/Procedure

1Biological Therapy
05/2015
1Therapeutics
08/2012